Dr. Felipe Camargo

Human Reproduction Biology , Instituto Valenciano De Infertilidad, España

Professional ID 4452501

Ingenes Mexico City

"The family is my most important project."

Dr. Felipe Camargo is one of the most prestigious fertility specialists in Mexico. In addition to contributing to the continuous improvement of Assisted Reproduction techniques in conjunction with some of the most important research centers in the country. He has helped more than 10,000 couples with fertility problems and, since 2005, ensures medical, scientific and emotional care of each of the patients of the Ingenes Institute, of which he is also founder.

After specializing in Gynecology and Obstetrics at the Universidad del Rosario in Bogotá, Colombia, he made two subspecialties at the San José Hospital, in the same city: one in Gynecology and Obstetrics and another in Infertility and Genetics. In addition, he studied the Master in Human Reproduction at the University of Valencia, in Spain, and during his 14 years of experience, he has been medical director of several international Assisted Reproduction institutes.

Also, Dr. Felipe Camargo has participated in more than 40 national and international scientific publications, he has been awarded with several awards. He is an active member of the Mexican Association of Reproductive Medicine (AMMR), the American Society of Reproductive Medicine ( ASRM), the Canadian Fertility Society and has participated in the acceptance of work in congresses of leading organizations in the field of fertility and genetics, such as the Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).

SPECIALIZATIONS:

Human Reproduction Biology ID: 4452501
Instituto Valenciano De Infertilidad, España


Publications

American Society for Reproductive Medicine 2014. Honolulu, Hawaii, E.U.A. 18 al 22 de octubre, 2014. E. Shcaeffer, J. Pedraza, F. Camargo, E. López-Bayghen. Biomarkers for ovarian endometriosis in folicular fluid. Fertility and Sterility. Resumen P-458:e289.


51 Mexican Congress of Reproduction Medicine. July 16-19, 2014. Huatulco Oaxaca; Participation as co- author. Works: 1) Turner syndrome Mosaic and pregnancy with newborn of high complexity, 2) Preliminary study of the use of our Institute of stripper technique as an embryo biopsy method on day 3 of development of the Genetic Diagnosis programs Preimplantation, 3) Predictive value of HCG-β for viable pregnancy in transfer of embryos thawed in the Instituto Ingenes México, 4) Correlation between serum and salivary levels of estradiol in patients who undergo In Vitro Fetilization treatment, 5) Medical management Successful non- surgical cervical ectopic pregnancy: A case report, 6) Clinical results by using single step culture medium from fertilization to the blastocyst stage vs. the first use of a fertilization medium and then the single medium step in 1332 patients under 40 years of age, 7) About an ovarian stimulation protocol that e combines the benefits of the Stop protocol with the qualities of the GnRH agonists, 8) Comparison of the pregnancy rate with transfer of frozen embryos on day 3 and 5 of development, 9) The use of monoculture in donation programs of oocytes in combination with a pH of 7.2 in the culture medium improves pregnancy rates compared to more alkaline pHs, 10) Reproductive phenotypes of polycystic ovary syndrome PCOS and results in assisted reproduction, 11) Final induction of final maturation of oocytes in donor cycles, 12) Embryo transfer pregnancy rates on day 3 vs day 5, 13) Experience in the use of flare-up stimulation protocol in patients with low ovarian response.


50th Mexican Congress of Reproduction Medicine. July 24-27, 2013. Cancun, Mexico; Participation as co- author. Works: 1) TSH levels and their Association with pregnancy rates in Infertile Women managed with In Vitro Fertilization, 2) The presence of smooth endoplasmic reticulum (aREL) groupings in the cytoplasm of at least one oocyte of donor oocyte cohorts affects clinical outcomes in vitro, 3) Casuistry of successful pregnancies after Psycho-Corporal Therapy in patients undergoing Assisted Reproduction, 4) Experience of the use of GnRH analogue + 1500UI of Human Chorionic Gonadotropin (hCG) as the final inducer of ovulation in cycles of In Vitro Fertilization (IVF) in patients with high response, 5) Comparative study of embryonic culture media.


XXXVII National Congress of Human Genetics. November 20-23, 2012. Guadalajara, Jalisco: Works: 1) Ocampo-Barcenas Azucena, Felipe Camargo Diaz, Hugo Sierra, Marcía Carmona, Laura Chiquillo, Esther López Bayghen. Profile of Gene Expression in Granulosa Cells: its use in the evaluation of Ovular Quality. 2) García-Flores Valeria, Azucena Ocampo, Felipe Camargo Díaz, Esther López Bayghen. Expression profile in endometrial cells and its relationship with endometrial receptivity.


49th Mexican Congress of Reproduction Medicine. 11-14 July, 2012. Puerto Vallarta, Jalisco; Participation as co-author. Works: 1) Mild stimulation vs conventional stimulation; comparison of cost benefit, in vitro fertilization cycles, 2) Endometrial preparation for transfer of frozen embryos: is the natural cycle better ?, 3) Comparison of endometrial preparation cycles with estradiol valerate vs. estradiol hemihydrate in donation program ovules, 4) Clinical results in patients with Müllerian malformations subjected to cycles of assisted reproduction, 5) Results in embryo quality and gestation rate with the use of pentoxifylline in sperm capacitation with altered male factor, 6) Impact of mass index in the cycles of in vitro fertilization stimulation, 7) Clinical results in patients with endometrioma undergoing controlled ovarian hyperstimulation in in vitro fertilization cycles, 8) Use of GnRH analogues to trigger ovulation in patients with high response in cycles of in vitro fertilization. in vitro fertilization. A safe option to prevent ovarian hyperstimulation syndrome.


47th Mexican Congress of Reproduction Medicine. 21-24 July, 2010. Mexico, D.F .; Participation as co- author. Works: 1) Experience of the medical treatment of metrotexate in patients with ectopic pregnancy after assisted reproduction techniques, 2) Obesity as a risk factor for early gestational loss in cycles of in vitro fertilization, 3) Effect of the start day of the antagonist in cycles of controlled ovarian hyperstimulation, 4) Embryo transfer technique as a predictor for clinical results in an egg donation program, 5) Use of folinic acid in patients with repeated loss of pregnancy: case report, 6) Later perinatal results to perform myomectomy open, 7) Clinical results according to the endometrial thickness of the patients receiving the egg donation program, 8) Effect of treatment with L-carnitine on sperm motility, 9) Intracytoplasmic injection with sperm obtained from the epididymis and testicle in patients with vasectomy, 10) Influence of n number of oocytes captured in clinical outcomes in patients undergoing IVF.


XLVI Annual Meeting of the Mexican Association of Reproduction Medicine, A.C., Ixtapa, Zihuatanejo; Participation as co-author. Works: 1) Embryonic viability in prolonged culture of embryos, 2) Effect of metformin in patients with Polycystic Ovarian Syndrome in in vitro fertilization cycles, 3) Use of menotropins on the day of HCG firing, 4) Duration of preparation endometrial donation of ovules, 5) Transfer on day 5 is better than transfer on day 3, 6) Effect of sibutramine on patients with overweight polycystic ovary syndrome undergoing in vitro fertilization cycles, 7) Sperm morphology is a good predictor of in vitro fertilization cycles with ICSI, 8) BhCG fraction level 14 days after follicular aspiration as a predictor of the evolution of pregnancy, 9) Clinical results in ovule donation cycles according to the Initial dose of menotropins.

 

  • Professional ID 4452501